Advisory - Two lots of the epilepsy drug Primidone recalled because of high levels of lead, which may pose serious health risks
OTTAWA, April 6, 2018 /CNW/ -
Issue Health Canada is advising Canadians that AA Pharma Inc. is voluntarily recalling two lots of Primidone tablets because they contain high levels of lead. The company has indicated that only the lots identified below are affected by this issue.
Primidone is a prescription anti-epileptic drug used to control seizures. Lead is a heavy metal and can pose serious health risks when too much is ingested, particularly by children, and pregnant and breastfeeding women.
Who is affected
Consumers who have bought or used the affected product
Affected product
Product
Strength
DIN
Size/Format
Lot Number
Expiry
Primidone
125 mg
00399310
100 tablets
MT4040
05/2021
Primidone
250 mg
00396761
100 tablets
MM3274
10/2020
What consumers should do
Return the product to your pharmacy for replacement as soon as possible if you have product from the affected lots.
Do not stop taking Primidone without talking to your doctor. Stopping Primidone suddenly can cause serious problems, including seizures that may not stop.
Consult with your health care professional if you have taken these tablets and have health concerns.
Contact AA Pharma Inc. via Stericycle by calling 1-888-228-5053 or by email at [email protected] if you have questions about this recall.
Report adverse events to health products to Health Canada by calling toll-free at 1?866?234?2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1?800?267?9675, or complete an online complaint form.
Additional information for pharmacies:
Retail and hospital pharmacies that have dispensed these products are being asked by the company to contact individuals who have received the impacted lots and to recover units from the impacted lot for return. The company has sent a notice to wholesalers and distributors to communicate the recall and advise on what to do.
Pharmacies may contact AA Pharma Inc. via Stericycle at 1-888-228-5053 for further information on the recall.
What Health Canada is doing Health Canada is monitoring the company's recall. Should additional safety information be identified, Health Canada will take appropriate action and inform Canadians.
Background Lead consumed in excessive amounts poses serious health risks because it may accumulate in vital organs of the body. Toxic effects include miscarriage and other reproductive effects, kidney and brain damage, abdominal pain, anemia, loss of appetite, constipation, fatigue, sleeplessness, irritability, headache, changes in blood pressure, weakness, concentration problems, weight loss, and dizziness. Children, and pregnant and breastfeeding women are the most susceptible to the toxic effects.
Stay connected with Health Canada and receive the latest advisories and product recalls.
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...
Summary
Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV"). Approval for the delisting was received at...
L.A. Care Health Plan and Blue Shield of California Promise Health Plan today held a grand opening ceremony for their Community Resource Center (CRC) in West Los Angeles (West L.A.) at 11173 W. Pico Blvd in Los Angeles....